Business
16th Finance Commission: Are federal transfers moving from support to performance? – The Times of India
NEW DELHI: For decades, India’s fiscal federal system has had one core element that stood out: poorer states would be supported so that growth could be shared.The 16th Finance Commission has not broken that promise on paper. States will still receive 41 percent of the divisible pool of central taxes. But beneath that headline number, the logic of how money moves across the Union is beginning to change.For the first time, economic output shapes transfers. Long-running revenue deficit grants — once a fiscal buffer for states — have been eliminated. Parts of local government funding are now tied to performance benchmarks. Disaster funding is moving towards risk-indexed allocation rather than discretionary relief.The shift is subtle in design but important in consequence. Transfers are no longer only about closing gaps. They are increasingly about shaping behaviour — rewarding growth, nudging fiscal discipline, and linking public money to administrative capacity.“Considering India’s growth imperative, there is a need for at least a small shift in the devolution criteria towards efficiency,” the Commission said, capturing the direction of travel.
What a Finance Commission decides
Under Article 280 of the Constitution, a Finance Commission is appointed roughly every five years to recommend how Union tax revenues are shared with states and how that share is distributed among them.The 16th Commission covers the period from 2026-27 to 2030-31. Its recommendations come at a time when India is expected to remain one of the fastest-growing major economies and set to become world’s third largest economy in the recommendation period.

The core decisions are twofold. Vertical devolution determines what share of central taxes goes to states. Horizontal devolution determines how that pool is divided among them. The vertical share remained unchanged. The horizontal framework has changed.

GDP contribution enters the formula
For the first time, contribution to national GDP has been included as a horizontal devolution criterion with a 10 percent weight. Karnataka gains 0.48 percentage points. Kerala gains 0.45 percentage point. Madhya Pradesh loses 0.50 percentage point. Bihar loses 0.11 percentage points . The formula now combines income distance, population, demographic performance, area, forest, GDP contribution. Income distance continues to drive equalisation. GDP contribution introduces an efficiency signal.In response to TOI queries, DK Srivastava, Chief Policy Advisor at EY India, questioned the conceptual basis.“Linking devolution to production efficiency does not appear to be justified,” he said.He said variation in state GDP contribution reflects structural economic factors rather than fiscal management.“It is important to distinguish between efficiency of a production system and efficiency of a fiscal system. GSDPs and GDP are the outcome of the production system in a country which is largely driven by market forces. Inter-state variation in the contribution of the GSDP of an individual state to the overall GDP depends largely on the inter-state concentration of capital stock, inter-state movement of financial and human resources and state level availability of infrastructure,” Srivastava said.He said fiscal rules themselves reinforce divergence.“The differences in inter-state infrastructure depends largely on the limit of fiscal deficit of 3% of GSDP which is by definition higher for higher GSDP states,” he said. “Lowering of the weight attached to the income distance criterion and giving a relatively high weight to the contribution criterion would reduce the degree of equalization.”Ranen Banerjee, Partner and Leader, Economic Advisory, PwC India, said the change sends a policy signal rather than creating an immediate redistribution shock.“The introduction of contribution to GDP as a parameter is a bold step as it clearly puts growth and consequent improvement in the per capita incomes of citizens as an important imperative,” he told TOI.

He said states are already competing on growth and investment metrics.“The states have been competing in attracting investments and improving their ease of doing business as well as articulating ambitious growth targets,” Banerjee said. “The signalling through this indicator could possibly work towards restraining populist expenditures and encouraging capital output enhancing expenditures that lead to economic growth.”He added the numerical impact remains modest.“While this may not be counted as a structural shift given the highest negative impact of just 50 basis points in the share of a state with all the changes in the weights and introduction of this parameter, it is a big incentive for states to perform well and provide growth to its population,” he said.Rumki Majumdar, Economist at Deloitte India, said the shift formally introduces performance into federal fiscal thinking.“The introduction of GDP contribution marks an important evolution: for the first time, economic performance finds measured recognition in horizontal devolution,” she said.
Revenue deficit grants end
The Commission has eliminated revenue deficit grants entirely, ending a mechanism historically used to support fiscally weaker states.The Commission’s reasoning is behavioural. It argues that persistent revenue support created ‘adverse incentive structures’ and weakened fiscal reform pressure.Srivastava said stronger design could still have been built around subsidy discipline.“One possible approach could have been to more explicitly exclude excessive or unjustified subsidies in the assessment of states’ expenditure needs during the award period,” he said. “Designing calibrated fiscal incentives or disincentives linked to subsidy discipline may enhance accountability.”
Local body transfers: performance now matters
Local bodies will receive Rs 7.91 lakh crore between 2026 and 2031, with 60 percent going to rural bodies and 40 percent to urban bodies.

Within this, 80 percent is basic grants and 20 percent is performance-linked.Performance conditions include audited accounts publication, property tax system strengthening, and own revenue growth targets.Majumdar said transparency reform is foundational.“Uniform on-budget reporting becomes the first step toward discipline,” she said.She said transparency alone is insufficient without incentive design.“A shift to uniform, on-budget accounting will ensure states remain committed to the path of fiscal prudence. That said, transparency will have to paired with targeted incentives for efficiency and progressive designs,” she said.
Disaster funding
The Commission has expanded formula-based disaster allocations using a disaster risk index based on hazard, exposure and vulnerability.Banerjee said the framework attempts to balance predictability with flexibility.“The sixteenth finance commission’s disaster relief and mitigation fund related recommendations have built in fiscal flexibility,” he said.He said extreme disaster funding scales with the size of the event.“The risk to extreme tail end disaster events that essentially entails relief has been adequately provided for with a graded contribution from states and centre based on the size of relief,” he said.He said fund stockpiling is controlled while allowing emergency replenishment.“The commission has also recommended capping of accumulation in the SDRF to the extent of past 3 years allocation,” he said.“In the event the fund gets depleted on account of a disaster, it has given provision for its replenishment,” he said.He said mitigation spending remains underused.“The challenge has been utilisation of the State Disaster Mitigation Funds,” he said.“Work on mitigation measures utilising the mitigation funds will be the best way to bring down the risks to be within modelled risk scenarios,” he said.Srivastava said tail-risk disasters remain a central government stabilisation responsibility.“Tail-risk disasters refer to high impact, low probability events such as natural disasters and pandemics,” he said.
(Credit -Sandeep Adhwaryu)
“In the macro-fiscal stabilization framework, dealing with these disasters is largely the responsibility of the central government,” he said.He said fiscal rule flexibility may be necessary in extreme events.“This calls for some flexibility in the fiscal deficit to GDP targets provided in the Centre’s FRBM Act,” he said.He cited pandemic precedent.“For events such as Covid-19 also, it was the central government that increased its fiscal deficit to an inordinately high level of 9.2% of GDP in 2020-21 to cope with the Covid led economic contraction,” he said.He said long-term catastrophic planning remains incomplete.“There is also a case to plan for dealing with disasters like pandemics, nuclear and biological holocausts in advance,” he said.Majumdar framed the shift as systemic resilience building.“When the next black swan arrives, the question is not whether models predicted it, but whether financing can move at the speed of need,” she said.“By modernising risk indices, widening eligibility and introducing market-based risk transfer, the framework somewhat ensures that public finances retain the agility required for a new era of tail-risk volatility,” she said.
Subsidy discipline
The Commission has recommended subsidy rationalisation, improved targeting, sunset clauses and stronger disclosure.Banerjee said fiscal deficit limits already create indirect discipline.“The fiscal federalism structure has an in-built mechanism that penalises fiscal profligacy by states,” he said.“This is through capping of the fiscal deficit that means limiting the borrowing that a state can undertake,” he said.He said adjustment pressures fall on capital spending.“When states are faced with serious fiscal constraints on account of excessive subsidy, the borrowing limit forces it to rationalise expenses,” he said.“Given the rigidity of expenditure for salaries, pension and interest payments, the casualty of such rationalisation is the capital expenditure,” he said.
Representative image
He said transparency can create market pressure.“More transparency on the fiscal condition of a state should upward pressure on the yields of the state development loans raised by the states making borrowing more expensive,” he said.Srivastava said stronger incentive architecture could have been considered.“One possible approach could have been to more explicitly exclude excessive or unjustified subsidies in the assessment of states’ expenditure needs,” he said.“Designing calibrated fiscal incentives or disincentives linked to subsidy discipline may enhance accountability,” he said.
A quieter federal shift
The Commission does not abandon equalisation. Income distance remains the dominant driver.But incentive-linked federalism now sits alongside support-based transfers.Growth versus redistribution, performance versus protection and fiscal discipline versus political economy pressures now operate within the same transfer structure.Over the next five years, states will adjust spending, borrowing and welfare design around this framework.
Business
FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market
The U.S. Food and Drug Administration approved Eli Lilly‘s GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight-loss medications.
Lilly said the once-daily pill, Foundayo, will start shipping from direct-to-consumer platform LillyDirect on Monday and will be available at pharmacies and on telehealth platforms “shortly after.” People with insurance coverage could pay $25 a month with a coupon from Lilly, while people paying out of pocket could pay between $149 and $349, depending on the dose.
The approval comes just a few months after Lilly submitted the drug to the FDA as part of a program that grants speedy reviews for drugs that are considered national priority interests. That means Lilly will introduce its Foundayo only about three months behind Novo Nordisk’s Wegovy pill, setting the stage for the next battle between the rival drugmakers in the next frontier for GLP-1 drugs.
“It’s a big moment,” Eli Lilly CEO Dave Ricks said in an interview with CNBC. “We’ve obviously been working in this category of medicines for a while with the first GLP-1 medication 20 years ago and improving ever since. Here is an option that’s not more effective … but it’s more accessible, it’s easier to fit into your daily routine.”
Lilly licensed the molecule, orforglipron, from Japanese drugmaker Chugai in 2018, paying just $50 million upfront for global rights to the drug. But there are still questions about how big the drug will become. It doesn’t produce as much weight loss as Lilly’s best-selling shot Zepbound. Millions of people are already used to the routine of injecting themselves once a week.
Eli Lilly Foundayo GLP-1 weight loss pill.
Courtesy: Eli Lilly
Analysts estimate Foundayo sales will reach $14.79 billion by 2030, according to FactSet. That compares to expectations of $24.68 billion for the weight-loss drug Zepbound and $44.87 billion for Mounjaro, which is marketed for diabetes in the U.S. and obesity and diabetes in the rest of the world.
Ricks said shots haven’t been as big of a barrier to uptake as Lilly once thought they would be. He still sees Foundayo as an attractive option for people who would rather take a pill or who are searching for a lower price than the injectables.
He sees it playing a role in maintenance, for people who achieve their goal weight with a shot and want to keep the weight off. And he sees Foundayo as a way to “reach the planet” without manufacturing constraints or cold-chain requirements that come with Zepbound.
Foundayo is a small molecule whereas Zepbound and Wegovy are peptides, which require more intensive manufacturing processes, a barrier Ricks thinks will hinder generic versions of Wegovy that have recently launched in some other countries like India.
“[Foundayo] does allow for scalability, and that will allow us to launch this globally on the first instance,” Ricks said. “So today, you can get the oral [Wegovy] in the U.S., but you really can’t get it elsewhere. This will be marketed around the world. As soon as we have regulatory approvals, we essentially have as much scale as we need to supply the world with an oral GLP-1 inhibitor.”
Lilly expects approval for Foundayo in more than 40 countries over the next year. The company since 2020 has invested more than $55 billion in manufacturing, which includes opening new sites and expanding existing plants to produce the pill.
In the U.S., Lilly will compete with Novo’s newly launched Wegovy pill. Early demand for that pill has been stronger than expected, with Novo reporting more than 600,000 prescriptions in March.
Novo CEO Mike Doustdar told CNBC in February that one of the earliest takeaways from the launch is that the pill appears to be expanding the obesity treatment market, drawing in new patients rather than converting existing ones from injections. Ricks agreed with that assessment and said Lilly doesn’t care whether people take Foundayo or Zepbound.
“We want people to be on the medicine that meets their health goals,” Ricks said. “If it has Lilly on the box, that’s the goal we have.”
Novo plans to argue that the Wegovy pill is more effective than Foundayo. The Wegovy pill showed around 16.6% weight loss on average in a late-stage trial, while Lilly’s oral drug caused roughly 12.4% on average in a separate study, when analyzing patients who stayed on treatment. Lilly’s Zepbound has consistently shown it can help people lose more than 20% of their body weight.
Meanwhile, Lilly plans to tout the fact that Foundayo can be taken any time without any restrictions, while the Wegovy pill needs to be taken first thing in the morning on an empty stomach with only a few ounces of water.
Where the two drugs are the same is the starting price. The lowest doses of both drugs will cost $149 for cash-paying customers thanks to an agreement the companies struck with the Trump administration last fall. And price is the most important factor for patients, said Dr. Nidhi Kansal, an obesity medicine doctor at Northwestern Medicine.
“Unfortunately, price is what is driving the decision making between clinicians and patients for these drugs because they’re all excellent drugs and we have lots of options now, but it’s still a financial decision at the end of the day,” Kansal said.
The lower price point and the approachability of a pill versus a shot opens up the market to casually interested patients, said BMO Capital Markets analyst Evan David Seigerman. Seniors on Medicare will be able to access Foundayo and other GLP-1 obesity medicines for $50 a month starting this summer as part of Lilly and Novo’s deals with the Trump administration. Ricks expects a “pretty robust” response to the program, which Lilly built into its financial guidance for the year.
Analysts say a successful launch of Foundayo is key to Lilly’s stock recovering from recent weakness. The company’s shares have fallen about 14% this year after a meteoric rise that briefly made Lilly the first trillion dollar market cap health-care company. Sales are a lagging indicator, so analysts will be tracking prescriptions to monitor uptake of the pill, said Cantor Fitzgerald analyst Carter Gould.
“If scripts are going in the right direction, and you’re seeing the continued gains, my guess is people will look through any sort of choppiness around [the first or second quarter],” Gould said.
Another factor for Lilly’s performance this year is a forthcoming readout for its more potent obesity shot, retatrutide. The company has already shared some late-stage data on that drug, but the most important trial is one studying the treatment specifically for weight loss. If retatrutide lives up to its expectations, Lilly would be on its way to creating a portfolio of obesity medicines.
“The future will be more choices, and that’s a great thing,” Ricks said. “And we hope Lilly is the one presenting those choices.”
Business
UPI transactions hit record Rs 29.53 lakh crore in March; volumes cross 22.6 billion – The Times of India
Unified Payments Interface (UPI) transactions touched a record high in March, with both value and volume hitting new peaks, driven by festive spending and financial year-end activity, according to PTI.Data released by the National Payments Corporation of India (NPCI) showed that UPI transactions totalled Rs 29.53 lakh crore in value during March, up 19 per cent from Rs 24.77 lakh crore in the same month last year.On a month-on-month basis, transaction value rose 10 per cent from Rs 26.84 lakh crore recorded in February.In volume terms, UPI registered 22.64 billion transactions during the month, marking a 24 per cent increase from 18.3 billion transactions a year ago. The volume was 20.39 billion in February.Average daily transactions stood at 730 million, with an average daily value of Rs 95,243 crore, as spending picked up during festivals such as Holi and Eid.“The sustained growth in the digital payment ecosystem in India is an affirmation of the penetration of real-time payment systems in the day-to-day life of the people. UPI processed 22.64 billion transactions worth 29.53 lakh crore in March 2026, marking its emergence as one of the trusted payment systems in the country,” said Anand Kumar Bajaj, MD & CEO of PayNearby.UPI now accounts for around 85 per cent of all digital transactions in India and contributes nearly 50 per cent of global real-time digital payments.The platform is operational in seven countries, including the UAE, Singapore, Bhutan, Nepal, Sri Lanka, France and Mauritius, with its entry into France marking its first expansion into Europe.NPCI, an initiative of the Reserve Bank of India and the Indian Banks’ Association, operates UPI, enabling real-time peer-to-peer and merchant payments across the country.
Business
Minimum wage rises to £12.71 an hour as firms warn of impact
But Spencer says his business is being squeezed from every angle – as well as minimum wage, he has had increases in business rates, national insurance, and statutory sick pay. He also expects energy bills to go up because of the war in the Middle East.
-
Politics1 week agoAfghanistan announces release of detained US citizen
-
Tech1 week agoCan a Home Appliance Fix the Problem of Soft-Plastic Waste?
-
Sports1 week agoBroadcast industry CEO says consolidation is ‘essential’ to compete for NFL soaring media rights prices
-
Entertainment1 week agoUN warns migratory freshwater fish numbers are spiralling
-
Business1 week agoProperty Play: Home flippers see smallest profits since the Great Recession, real estate data firm says
-
Business1 week agoGold prices soar in Pakistan – SUCH TV
-
Business1 week agoMore women are entering wealth management, but few are in advisory roles, study finds
-
Fashion1 week agoICE cotton slips on weaker crude, profit booking
